15.04.2015 • NewsDevelopmentfootprintmarketing

Recipharm Buys Synthonics Preferred Stock

Swedish drugmaker Recipharm has acquired $2 million worth of preferred stock in Synthonics and has promised to buy an additional $2 million of the stock, contingent on the US metal coordination chemistry specialist achieving certain milestones expected during 2016.

In connection with the investment, Recipharm's Carl-Johan Spak has joined Synthonics' board of directors.

Additionally, the two companies have signed a joint development agreement, giving Synthonics access to Recipharm's expertise in drug development, marketing and manufacturing in exchange for a royalty payment on certain compounds.

The pharmaceutical firms first began collaborating in 2013 with the signing of a joint marketing built around Synthomer's drug delivery technology for metal coordination of pharmaceutical APIs.

Synthonics CEO Ken Slepicka said his company is "delighted" to join Recipharm in helping advance promising molecules to market. He added that the agreement and financial support "will help us further advance several of our current projects to commercialization."

Carl-Johan Spak, executive vice president, technology and development at Recipharm, said the transaction expands the Swedish company's footprint in the US and builds on the existing joint marketing agreement with Synthonics.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.